Leonard L. Mazur, Director at Citius Pharmaceuticals, Inc. (CTXR), bought 20,116,746 shares at $0.60 ($3.0M) on 2016-03-30, disclosed to the SEC on 2016-04-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,116,746 | $0 | 0.0% |
| 2 | $0.60 | 5,000,000 | $3.0M | 100.0% |
| Total | $0.15 avg | 20,116,746 | $3.0M | 100% |
| Filing → |
| CTXR | BUY | 2019-04-05 | $3.6M | — | Filing → |
| CTXR | BUY | 2018-08-15 | $8.0M | — | Filing → |
| CTXR | BUY | 2018-04-02 | $1.0M | — | Filing → |